Glasdegib with LDAC in Newly Diagnosed Patients with Acute Myeloid Leukemia (AML) Unsuitable for Intensive Chemotherapy: Effects on Transfusions and Marrow Recovery vs LDAC Alone

被引：1

作者：

Wang, Eunice S. ^{[1
]}

Heuser, Michael ^{[2
]}

Montesinos, Pau ^{[3
,4
]}

Sekeres, Mikkael A. ^{[5
]}

Merchant, Akil ^{[6
]}

Pedro Olive, Carmen ^{[7
]}

Salamero, Olga ^{[8
]}

McCloskey, James K. ^{[9
]}

Hoang, Caroline J. ^{[10
]}

Ma, Weidong Wendy ^{[10
]}

Zeremski, Mirjana ^{[10
]}

O'Connell, Ashleigh ^{[10
]}

Chan, Geoffrey ^{[10
]}

Cortes, Jorge E. ^{[11
]}

机构：

[1] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[2] Hannover Med Sch, Hannover, Germany

[3] Hosp Univ & Politecn La Fe, Valencia, Spain

[4] Inst Salud Carlos III, CIBERONC, Madrid, Spain

[5] Cleveland Clin, Cleveland, OH 44106 USA

[6] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[7] Hosp del Mar, Barcelona, Spain

[8] Valle dHebron Hosp, Barcelona, Spain

[9] John Theurer Canc Ctr, Hackensack, NJ USA

[10] Pfizer Inc, New York, NY USA

[11] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

关键词：

acute myeloid leukemia; glasdegib; low-dose cytarabine; cytopenia; transfusion; AML;

D O I：

10.1016/j.clml.2019.07.114

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AML-282

引用

页码：S230 / S230

页数：1